BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33804108)

  • 1. Prognostic and Clinicopathological Significance of
    González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ramos-García P
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.
    Ramos-García P; González-Moles MÁ; González-Ruiz L; Ruiz-Ávila I; Ayén Á; Gil-Montoya JA
    Oral Oncol; 2018 Aug; 83():96-106. PubMed ID: 30098785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of CCND1/cyclin D1 alterations in the malignant transformation of potentially malignant head and neck disorders: Systematic review and meta-analysis.
    Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Gil-Montoya JA; Ruiz-Ávila I
    Head Neck; 2019 Sep; 41(9):3395-3407. PubMed ID: 31184805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and Predictive Value of
    Jeffreys SA; Becker TM; Khan S; Soon P; Neubauer H; de Souza P; Powter B
    Front Endocrinol (Lausanne); 2022; 13():895729. PubMed ID: 35784572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
    Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
    Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
    Reis-Filho JS; Savage K; Lambros MB; James M; Steele D; Jones RL; Dowsett M
    Mod Pathol; 2006 Jul; 19(7):999-1009. PubMed ID: 16648863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
    Elsheikh S; Green AR; Aleskandarany MA; Grainge M; Paish CE; Lambros MB; Reis-Filho JS; Ellis IO
    Breast Cancer Res Treat; 2008 May; 109(2):325-35. PubMed ID: 17653856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
    PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters.
    Mohammedi L; Doula FD; Mesli F; Senhadji R
    Afr Health Sci; 2019 Jun; 19(2):2140-2146. PubMed ID: 31656498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.
    Jiang Y; Zhang C; Lu L; Wang X; Liu H; Jiang Y; Hong L; Chen Y; Huang H; Guo D
    Technol Cancer Res Treat; 2022; 21():15330338211065252. PubMed ID: 35098809
    [No Abstract]   [Full Text] [Related]  

  • 13. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
    Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    González-Moles MÁ; Ayén Á; González-Ruiz I; de Porras-Carrique T; González-Ruiz L; Ruiz-Ávila I; Ramos-García P
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
    Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis.
    Zhao Y; Yu D; Li H; Nie P; Zhu Y; Liu S; Zhu M; Fang B
    PLoS One; 2014; 9(3):e93210. PubMed ID: 24675814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.
    Miyamoto R; Uzawa N; Nagaoka S; Hirata Y; Amagasa T
    Oral Oncol; 2003 Sep; 39(6):610-8. PubMed ID: 12798405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
    Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
    Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.
    Li Y; Wei J; Xu C; Zhao Z; You T
    PLoS One; 2014; 9(4):e94508. PubMed ID: 24728073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.